NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

6. The data collection validation was, continued, imho, so that it could at least validate until four years past the last patients surgery. They have now gone further beyond four years past last patient's enrollment. Essentially, they stated in their most recent 10Q that they have returned to consulting with the SAB about when to end the trial. This is disappointing, as it seems to be contrary to the steps to data lock precisely laid out by Dr. Bosch back in June 2019.

Flipper44,

I would rather think that it is LP way of telling us that many patients are still alive between 4 and 5 years on the OS curve.